Global Meloxicam Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Meloxicam is an enol nonsteroidal anti-inflammatory drug with anti-inflammatory, analgesic and antipyretic effects.Selective inhibition of cox-2 (cox-2), the inhibition of cox-1 is weak, so the digestive system and other adverse reactions are less.
LPI (LP Information)' newest research report, the “Meloxicam Industry Forecast” looks at past sales and reviews total world Meloxicam sales in 2022, providing a comprehensive analysis by region and market sector of projected Meloxicam sales for 2023 through 2029. With Meloxicam sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Meloxicam industry.
This Insight Report provides a comprehensive analysis of the global Meloxicam landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Meloxicam portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Meloxicam market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Meloxicam and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Meloxicam.
The global Meloxicam market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Meloxicam is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Meloxicam is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Meloxicam is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Meloxicam players cover Boehringer Ingelheim, Baudax, Perrigo, Recro Pharma, Iroko Pharma, Zyla Life Sciences, Axsome Therapeutics, Orbis Biosciences and Cellix Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Meloxicam market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Meloxicam market?
What factors are driving Meloxicam market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Meloxicam market opportunities vary by end market size?
How does Meloxicam break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Meloxicam is an enol nonsteroidal anti-inflammatory drug with anti-inflammatory, analgesic and antipyretic effects.Selective inhibition of cox-2 (cox-2), the inhibition of cox-1 is weak, so the digestive system and other adverse reactions are less.
LPI (LP Information)' newest research report, the “Meloxicam Industry Forecast” looks at past sales and reviews total world Meloxicam sales in 2022, providing a comprehensive analysis by region and market sector of projected Meloxicam sales for 2023 through 2029. With Meloxicam sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Meloxicam industry.
This Insight Report provides a comprehensive analysis of the global Meloxicam landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Meloxicam portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Meloxicam market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Meloxicam and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Meloxicam.
The global Meloxicam market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Meloxicam is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Meloxicam is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Meloxicam is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Meloxicam players cover Boehringer Ingelheim, Baudax, Perrigo, Recro Pharma, Iroko Pharma, Zyla Life Sciences, Axsome Therapeutics, Orbis Biosciences and Cellix Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Meloxicam market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- by Ingredient
- Combination Drugs
- Prescribed Drugs
- by Route
- Oral
- Intravenou
- by Dosage Form
- Tablets
- Capsule
- Granules
- Other
- Rheumatoid Arthritis
- Osteoarthritis
- Soft Tissue Inflammation
- Traumatic Pain
- Post-Operative Pain
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boehringer Ingelheim
- Baudax
- Perrigo
- Recro Pharma
- Iroko Pharma
- Zyla Life Sciences
- Axsome Therapeutics
- Orbis Biosciences
- Cellix Bio
- Ligand Pharma
- SEDOR Pharma
- Heron Therapeutics
- Pacira BioSciences
- Sanofi
- Eurofarma Laboratorio
- TerSera Therapeutics
- Apotex
- Yung Shin Pharmaceutical
- Breckenridge Pharmaceutical
- Zydus Pharmaceuticals
- Unichem Pharmaceuticals
- Strides Pharma
- Cipla
- Dr. Reddy's Laboratories
- Glenmark Pharmaceuticals
- Teva
- PuraCap Pharmaceutical
- TARO
- Lupin Pharmaceuticals
- Aurobindo Pharma
- Shanghai Bolinger Ingelheim Pharmaceutical
- Shanghai Zhaohui Pharmaceutical
- Sichuan Shenghe Pharmaceutical
- Ningxia Kangya Pharmaceutical
- Yangtze Pharmaceutical Group
- Kunshan Longdeng Ruidi Pharmaceutical
- Jiangsu Yabang Epson Pharmaceutical
- Jiangsu Feima Pharmaceutical Co. , Ltd
- Zhejiang Xianju Pharmaceutical
- Hainan All Star Pharmaceutical
- Hainan Aomeihua Pharmaceutical
- Hunan Mingrui Pharmaceutical
- Suzhou Sinochem Pharmaceutical
- Qilu Pharmaceutical
- Sichuan Luye Pharmaceutical
- Shandong Xinhua Pharmaceutical
- Guangdong Renkang Pharmaceutical
- Hainan Selike Pharmaceutical
What is the 10-year outlook for the global Meloxicam market?
What factors are driving Meloxicam market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Meloxicam market opportunities vary by end market size?
How does Meloxicam break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Meloxicam Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Meloxicam by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Meloxicam by Country/Region, 2018, 2022 & 2029
2.2 Meloxicam Segment by Type
2.2.1 Combination Drugs
2.2.2 Prescribed Drugs
2.3 Meloxicam Sales by Type
2.3.1 Global Meloxicam Sales Market Share by Type (2018-2023)
2.3.2 Global Meloxicam Revenue and Market Share by Type (2018-2023)
2.3.3 Global Meloxicam Sale Price by Type (2018-2023)
2.4 Meloxicam Segment by Application
2.4.1 Rheumatoid Arthritis
2.4.2 Osteoarthritis
2.4.3 Soft Tissue Inflammation
2.4.4 Traumatic Pain
2.4.5 Post-Operative Pain
2.4.6 Other
2.5 Meloxicam Sales by Application
2.5.1 Global Meloxicam Sale Market Share by Application (2018-2023)
2.5.2 Global Meloxicam Revenue and Market Share by Application (2018-2023)
2.5.3 Global Meloxicam Sale Price by Application (2018-2023)
3 GLOBAL MELOXICAM BY COMPANY
3.1 Global Meloxicam Breakdown Data by Company
3.1.1 Global Meloxicam Annual Sales by Company (2018-2023)
3.1.2 Global Meloxicam Sales Market Share by Company (2018-2023)
3.2 Global Meloxicam Annual Revenue by Company (2018-2023)
3.2.1 Global Meloxicam Revenue by Company (2018-2023)
3.2.2 Global Meloxicam Revenue Market Share by Company (2018-2023)
3.3 Global Meloxicam Sale Price by Company
3.4 Key Manufacturers Meloxicam Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Meloxicam Product Location Distribution
3.4.2 Players Meloxicam Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MELOXICAM BY GEOGRAPHIC REGION
4.1 World Historic Meloxicam Market Size by Geographic Region (2018-2023)
4.1.1 Global Meloxicam Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Meloxicam Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Meloxicam Market Size by Country/Region (2018-2023)
4.2.1 Global Meloxicam Annual Sales by Country/Region (2018-2023)
4.2.2 Global Meloxicam Annual Revenue by Country/Region (2018-2023)
4.3 Americas Meloxicam Sales Growth
4.4 APAC Meloxicam Sales Growth
4.5 Europe Meloxicam Sales Growth
4.6 Middle East & Africa Meloxicam Sales Growth
5 AMERICAS
5.1 Americas Meloxicam Sales by Country
5.1.1 Americas Meloxicam Sales by Country (2018-2023)
5.1.2 Americas Meloxicam Revenue by Country (2018-2023)
5.2 Americas Meloxicam Sales by Type
5.3 Americas Meloxicam Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Meloxicam Sales by Region
6.1.1 APAC Meloxicam Sales by Region (2018-2023)
6.1.2 APAC Meloxicam Revenue by Region (2018-2023)
6.2 APAC Meloxicam Sales by Type
6.3 APAC Meloxicam Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Meloxicam by Country
7.1.1 Europe Meloxicam Sales by Country (2018-2023)
7.1.2 Europe Meloxicam Revenue by Country (2018-2023)
7.2 Europe Meloxicam Sales by Type
7.3 Europe Meloxicam Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Meloxicam by Country
8.1.1 Middle East & Africa Meloxicam Sales by Country (2018-2023)
8.1.2 Middle East & Africa Meloxicam Revenue by Country (2018-2023)
8.2 Middle East & Africa Meloxicam Sales by Type
8.3 Middle East & Africa Meloxicam Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Meloxicam
10.3 Manufacturing Process Analysis of Meloxicam
10.4 Industry Chain Structure of Meloxicam
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Meloxicam Distributors
11.3 Meloxicam Customer
12 WORLD FORECAST REVIEW FOR MELOXICAM BY GEOGRAPHIC REGION
12.1 Global Meloxicam Market Size Forecast by Region
12.1.1 Global Meloxicam Forecast by Region (2024-2029)
12.1.2 Global Meloxicam Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Meloxicam Forecast by Type
12.7 Global Meloxicam Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Meloxicam Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 Baudax
13.2.1 Baudax Company Information
13.2.2 Baudax Meloxicam Product Portfolios and Specifications
13.2.3 Baudax Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Baudax Main Business Overview
13.2.5 Baudax Latest Developments
13.3 Perrigo
13.3.1 Perrigo Company Information
13.3.2 Perrigo Meloxicam Product Portfolios and Specifications
13.3.3 Perrigo Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Perrigo Main Business Overview
13.3.5 Perrigo Latest Developments
13.4 Recro Pharma
13.4.1 Recro Pharma Company Information
13.4.2 Recro Pharma Meloxicam Product Portfolios and Specifications
13.4.3 Recro Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Recro Pharma Main Business Overview
13.4.5 Recro Pharma Latest Developments
13.5 Iroko Pharma
13.5.1 Iroko Pharma Company Information
13.5.2 Iroko Pharma Meloxicam Product Portfolios and Specifications
13.5.3 Iroko Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Iroko Pharma Main Business Overview
13.5.5 Iroko Pharma Latest Developments
13.6 Zyla Life Sciences
13.6.1 Zyla Life Sciences Company Information
13.6.2 Zyla Life Sciences Meloxicam Product Portfolios and Specifications
13.6.3 Zyla Life Sciences Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Zyla Life Sciences Main Business Overview
13.6.5 Zyla Life Sciences Latest Developments
13.7 Axsome Therapeutics
13.7.1 Axsome Therapeutics Company Information
13.7.2 Axsome Therapeutics Meloxicam Product Portfolios and Specifications
13.7.3 Axsome Therapeutics Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Axsome Therapeutics Main Business Overview
13.7.5 Axsome Therapeutics Latest Developments
13.8 Orbis Biosciences
13.8.1 Orbis Biosciences Company Information
13.8.2 Orbis Biosciences Meloxicam Product Portfolios and Specifications
13.8.3 Orbis Biosciences Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Orbis Biosciences Main Business Overview
13.8.5 Orbis Biosciences Latest Developments
13.9 Cellix Bio
13.9.1 Cellix Bio Company Information
13.9.2 Cellix Bio Meloxicam Product Portfolios and Specifications
13.9.3 Cellix Bio Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Cellix Bio Main Business Overview
13.9.5 Cellix Bio Latest Developments
13.10 Ligand Pharma
13.10.1 Ligand Pharma Company Information
13.10.2 Ligand Pharma Meloxicam Product Portfolios and Specifications
13.10.3 Ligand Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Ligand Pharma Main Business Overview
13.10.5 Ligand Pharma Latest Developments
13.11 SEDOR Pharma
13.11.1 SEDOR Pharma Company Information
13.11.2 SEDOR Pharma Meloxicam Product Portfolios and Specifications
13.11.3 SEDOR Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 SEDOR Pharma Main Business Overview
13.11.5 SEDOR Pharma Latest Developments
13.12 Heron Therapeutics
13.12.1 Heron Therapeutics Company Information
13.12.2 Heron Therapeutics Meloxicam Product Portfolios and Specifications
13.12.3 Heron Therapeutics Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Heron Therapeutics Main Business Overview
13.12.5 Heron Therapeutics Latest Developments
13.13 Pacira BioSciences
13.13.1 Pacira BioSciences Company Information
13.13.2 Pacira BioSciences Meloxicam Product Portfolios and Specifications
13.13.3 Pacira BioSciences Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Pacira BioSciences Main Business Overview
13.13.5 Pacira BioSciences Latest Developments
13.14 Sanofi
13.14.1 Sanofi Company Information
13.14.2 Sanofi Meloxicam Product Portfolios and Specifications
13.14.3 Sanofi Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Sanofi Main Business Overview
13.14.5 Sanofi Latest Developments
13.15 Eurofarma Laboratorio
13.15.1 Eurofarma Laboratorio Company Information
13.15.2 Eurofarma Laboratorio Meloxicam Product Portfolios and Specifications
13.15.3 Eurofarma Laboratorio Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Eurofarma Laboratorio Main Business Overview
13.15.5 Eurofarma Laboratorio Latest Developments
13.16 TerSera Therapeutics
13.16.1 TerSera Therapeutics Company Information
13.16.2 TerSera Therapeutics Meloxicam Product Portfolios and Specifications
13.16.3 TerSera Therapeutics Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 TerSera Therapeutics Main Business Overview
13.16.5 TerSera Therapeutics Latest Developments
13.17 Apotex
13.17.1 Apotex Company Information
13.17.2 Apotex Meloxicam Product Portfolios and Specifications
13.17.3 Apotex Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Apotex Main Business Overview
13.17.5 Apotex Latest Developments
13.18 Yung Shin Pharmaceutical
13.18.1 Yung Shin Pharmaceutical Company Information
13.18.2 Yung Shin Pharmaceutical Meloxicam Product Portfolios and Specifications
13.18.3 Yung Shin Pharmaceutical Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Yung Shin Pharmaceutical Main Business Overview
13.18.5 Yung Shin Pharmaceutical Latest Developments
13.19 Breckenridge Pharmaceutical
13.19.1 Breckenridge Pharmaceutical Company Information
13.19.2 Breckenridge Pharmaceutical Meloxicam Product Portfolios and Specifications
13.19.3 Breckenridge Pharmaceutical Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Breckenridge Pharmaceutical Main Business Overview
13.19.5 Breckenridge Pharmaceutical Latest Developments
13.20 Zydus Pharmaceuticals
13.20.1 Zydus Pharmaceuticals Company Information
13.20.2 Zydus Pharmaceuticals Meloxicam Product Portfolios and Specifications
13.20.3 Zydus Pharmaceuticals Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Zydus Pharmaceuticals Main Business Overview
13.20.5 Zydus Pharmaceuticals Latest Developments
13.21 Unichem Pharmaceuticals
13.21.1 Unichem Pharmaceuticals Company Information
13.21.2 Unichem Pharmaceuticals Meloxicam Product Portfolios and Specifications
13.21.3 Unichem Pharmaceuticals Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Unichem Pharmaceuticals Main Business Overview
13.21.5 Unichem Pharmaceuticals Latest Developments
13.22 Strides Pharma
13.22.1 Strides Pharma Company Information
13.22.2 Strides Pharma Meloxicam Product Portfolios and Specifications
13.22.3 Strides Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 Strides Pharma Main Business Overview
13.22.5 Strides Pharma Latest Developments
13.23 Cipla
13.23.1 Cipla Company Information
13.23.2 Cipla Meloxicam Product Portfolios and Specifications
13.23.3 Cipla Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 Cipla Main Business Overview
13.23.5 Cipla Latest Developments
13.24 Dr. Reddy's Laboratories
13.24.1 Dr. Reddy's Laboratories Company Information
13.24.2 Dr. Reddy's Laboratories Meloxicam Product Portfolios and Specifications
13.24.3 Dr. Reddy's Laboratories Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.24.4 Dr. Reddy's Laboratories Main Business Overview
13.24.5 Dr. Reddy's Laboratories Latest Developments
13.25 Glenmark Pharmaceuticals
13.25.1 Glenmark Pharmaceuticals Company Information
13.25.2 Glenmark Pharmaceuticals Meloxicam Product Portfolios and Specifications
13.25.3 Glenmark Pharmaceuticals Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.25.4 Glenmark Pharmaceuticals Main Business Overview
13.25.5 Glenmark Pharmaceuticals Latest Developments
13.26 Teva
13.26.1 Teva Company Information
13.26.2 Teva Meloxicam Product Portfolios and Specifications
13.26.3 Teva Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.26.4 Teva Main Business Overview
13.26.5 Teva Latest Developments
13.27 PuraCap Pharmaceutical
13.27.1 PuraCap Pharmaceutical Company Information
13.27.2 PuraCap Pharmaceutical Meloxicam Product Portfolios and Specifications
13.27.3 PuraCap Pharmaceutical Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.27.4 PuraCap Pharmaceutical Main Business Overview
13.27.5 PuraCap Pharmaceutical Latest Developments
13.28 TARO
13.28.1 TARO Company Information
13.28.2 TARO Meloxicam Product Portfolios and Specifications
13.28.3 TARO Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.28.4 TARO Main Business Overview
13.28.5 TARO Latest Developments
13.29 Lupin Pharmaceuticals
13.29.1 Lupin Pharmaceuticals Company Information
13.29.2 Lupin Pharmaceuticals Meloxicam Product Portfolios and Specifications
13.29.3 Lupin Pharmaceuticals Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.29.4 Lupin Pharmaceuticals Main Business Overview
13.29.5 Lupin Pharmaceuticals Latest Developments
13.30 Aurobindo Pharma
13.30.1 Aurobindo Pharma Company Information
13.30.2 Aurobindo Pharma Meloxicam Product Portfolios and Specifications
13.30.3 Aurobindo Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.30.4 Aurobindo Pharma Main Business Overview
13.30.5 Aurobindo Pharma Latest Developments
13.31 Shanghai Bolinger Ingelheim Pharmaceutical
13.32 Shanghai Zhaohui Pharmaceutical
13.33 Sichuan Shenghe Pharmaceutical
13.34 Ningxia Kangya Pharmaceutical
13.35 Yangtze Pharmaceutical Group
13.36 Kunshan Longdeng Ruidi Pharmaceutical
13.37 Jiangsu Yabang Epson Pharmaceutical
13.38 Jiangsu Feima Pharmaceutical Co. , Ltd
13.39 Zhejiang Xianju Pharmaceutical
13.40 Hainan All Star Pharmaceutical
13.41 Hainan Aomeihua Pharmaceutical
13.42 Hunan Mingrui Pharmaceutical
13.43 Suzhou Sinochem Pharmaceutical
13.44 Qilu Pharmaceutical
13.45 Sichuan Luye Pharmaceutical
13.46 Shandong Xinhua Pharmaceutical
13.47 Guangdong Renkang Pharmaceutical
13.48 Hainan Selike Pharmaceutical
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Meloxicam Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Meloxicam by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Meloxicam by Country/Region, 2018, 2022 & 2029
2.2 Meloxicam Segment by Type
2.2.1 Combination Drugs
2.2.2 Prescribed Drugs
2.3 Meloxicam Sales by Type
2.3.1 Global Meloxicam Sales Market Share by Type (2018-2023)
2.3.2 Global Meloxicam Revenue and Market Share by Type (2018-2023)
2.3.3 Global Meloxicam Sale Price by Type (2018-2023)
2.4 Meloxicam Segment by Application
2.4.1 Rheumatoid Arthritis
2.4.2 Osteoarthritis
2.4.3 Soft Tissue Inflammation
2.4.4 Traumatic Pain
2.4.5 Post-Operative Pain
2.4.6 Other
2.5 Meloxicam Sales by Application
2.5.1 Global Meloxicam Sale Market Share by Application (2018-2023)
2.5.2 Global Meloxicam Revenue and Market Share by Application (2018-2023)
2.5.3 Global Meloxicam Sale Price by Application (2018-2023)
3 GLOBAL MELOXICAM BY COMPANY
3.1 Global Meloxicam Breakdown Data by Company
3.1.1 Global Meloxicam Annual Sales by Company (2018-2023)
3.1.2 Global Meloxicam Sales Market Share by Company (2018-2023)
3.2 Global Meloxicam Annual Revenue by Company (2018-2023)
3.2.1 Global Meloxicam Revenue by Company (2018-2023)
3.2.2 Global Meloxicam Revenue Market Share by Company (2018-2023)
3.3 Global Meloxicam Sale Price by Company
3.4 Key Manufacturers Meloxicam Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Meloxicam Product Location Distribution
3.4.2 Players Meloxicam Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MELOXICAM BY GEOGRAPHIC REGION
4.1 World Historic Meloxicam Market Size by Geographic Region (2018-2023)
4.1.1 Global Meloxicam Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Meloxicam Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Meloxicam Market Size by Country/Region (2018-2023)
4.2.1 Global Meloxicam Annual Sales by Country/Region (2018-2023)
4.2.2 Global Meloxicam Annual Revenue by Country/Region (2018-2023)
4.3 Americas Meloxicam Sales Growth
4.4 APAC Meloxicam Sales Growth
4.5 Europe Meloxicam Sales Growth
4.6 Middle East & Africa Meloxicam Sales Growth
5 AMERICAS
5.1 Americas Meloxicam Sales by Country
5.1.1 Americas Meloxicam Sales by Country (2018-2023)
5.1.2 Americas Meloxicam Revenue by Country (2018-2023)
5.2 Americas Meloxicam Sales by Type
5.3 Americas Meloxicam Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Meloxicam Sales by Region
6.1.1 APAC Meloxicam Sales by Region (2018-2023)
6.1.2 APAC Meloxicam Revenue by Region (2018-2023)
6.2 APAC Meloxicam Sales by Type
6.3 APAC Meloxicam Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Meloxicam by Country
7.1.1 Europe Meloxicam Sales by Country (2018-2023)
7.1.2 Europe Meloxicam Revenue by Country (2018-2023)
7.2 Europe Meloxicam Sales by Type
7.3 Europe Meloxicam Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Meloxicam by Country
8.1.1 Middle East & Africa Meloxicam Sales by Country (2018-2023)
8.1.2 Middle East & Africa Meloxicam Revenue by Country (2018-2023)
8.2 Middle East & Africa Meloxicam Sales by Type
8.3 Middle East & Africa Meloxicam Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Meloxicam
10.3 Manufacturing Process Analysis of Meloxicam
10.4 Industry Chain Structure of Meloxicam
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Meloxicam Distributors
11.3 Meloxicam Customer
12 WORLD FORECAST REVIEW FOR MELOXICAM BY GEOGRAPHIC REGION
12.1 Global Meloxicam Market Size Forecast by Region
12.1.1 Global Meloxicam Forecast by Region (2024-2029)
12.1.2 Global Meloxicam Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Meloxicam Forecast by Type
12.7 Global Meloxicam Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Meloxicam Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 Baudax
13.2.1 Baudax Company Information
13.2.2 Baudax Meloxicam Product Portfolios and Specifications
13.2.3 Baudax Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Baudax Main Business Overview
13.2.5 Baudax Latest Developments
13.3 Perrigo
13.3.1 Perrigo Company Information
13.3.2 Perrigo Meloxicam Product Portfolios and Specifications
13.3.3 Perrigo Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Perrigo Main Business Overview
13.3.5 Perrigo Latest Developments
13.4 Recro Pharma
13.4.1 Recro Pharma Company Information
13.4.2 Recro Pharma Meloxicam Product Portfolios and Specifications
13.4.3 Recro Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Recro Pharma Main Business Overview
13.4.5 Recro Pharma Latest Developments
13.5 Iroko Pharma
13.5.1 Iroko Pharma Company Information
13.5.2 Iroko Pharma Meloxicam Product Portfolios and Specifications
13.5.3 Iroko Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Iroko Pharma Main Business Overview
13.5.5 Iroko Pharma Latest Developments
13.6 Zyla Life Sciences
13.6.1 Zyla Life Sciences Company Information
13.6.2 Zyla Life Sciences Meloxicam Product Portfolios and Specifications
13.6.3 Zyla Life Sciences Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Zyla Life Sciences Main Business Overview
13.6.5 Zyla Life Sciences Latest Developments
13.7 Axsome Therapeutics
13.7.1 Axsome Therapeutics Company Information
13.7.2 Axsome Therapeutics Meloxicam Product Portfolios and Specifications
13.7.3 Axsome Therapeutics Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Axsome Therapeutics Main Business Overview
13.7.5 Axsome Therapeutics Latest Developments
13.8 Orbis Biosciences
13.8.1 Orbis Biosciences Company Information
13.8.2 Orbis Biosciences Meloxicam Product Portfolios and Specifications
13.8.3 Orbis Biosciences Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Orbis Biosciences Main Business Overview
13.8.5 Orbis Biosciences Latest Developments
13.9 Cellix Bio
13.9.1 Cellix Bio Company Information
13.9.2 Cellix Bio Meloxicam Product Portfolios and Specifications
13.9.3 Cellix Bio Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Cellix Bio Main Business Overview
13.9.5 Cellix Bio Latest Developments
13.10 Ligand Pharma
13.10.1 Ligand Pharma Company Information
13.10.2 Ligand Pharma Meloxicam Product Portfolios and Specifications
13.10.3 Ligand Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Ligand Pharma Main Business Overview
13.10.5 Ligand Pharma Latest Developments
13.11 SEDOR Pharma
13.11.1 SEDOR Pharma Company Information
13.11.2 SEDOR Pharma Meloxicam Product Portfolios and Specifications
13.11.3 SEDOR Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 SEDOR Pharma Main Business Overview
13.11.5 SEDOR Pharma Latest Developments
13.12 Heron Therapeutics
13.12.1 Heron Therapeutics Company Information
13.12.2 Heron Therapeutics Meloxicam Product Portfolios and Specifications
13.12.3 Heron Therapeutics Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Heron Therapeutics Main Business Overview
13.12.5 Heron Therapeutics Latest Developments
13.13 Pacira BioSciences
13.13.1 Pacira BioSciences Company Information
13.13.2 Pacira BioSciences Meloxicam Product Portfolios and Specifications
13.13.3 Pacira BioSciences Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Pacira BioSciences Main Business Overview
13.13.5 Pacira BioSciences Latest Developments
13.14 Sanofi
13.14.1 Sanofi Company Information
13.14.2 Sanofi Meloxicam Product Portfolios and Specifications
13.14.3 Sanofi Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Sanofi Main Business Overview
13.14.5 Sanofi Latest Developments
13.15 Eurofarma Laboratorio
13.15.1 Eurofarma Laboratorio Company Information
13.15.2 Eurofarma Laboratorio Meloxicam Product Portfolios and Specifications
13.15.3 Eurofarma Laboratorio Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Eurofarma Laboratorio Main Business Overview
13.15.5 Eurofarma Laboratorio Latest Developments
13.16 TerSera Therapeutics
13.16.1 TerSera Therapeutics Company Information
13.16.2 TerSera Therapeutics Meloxicam Product Portfolios and Specifications
13.16.3 TerSera Therapeutics Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 TerSera Therapeutics Main Business Overview
13.16.5 TerSera Therapeutics Latest Developments
13.17 Apotex
13.17.1 Apotex Company Information
13.17.2 Apotex Meloxicam Product Portfolios and Specifications
13.17.3 Apotex Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Apotex Main Business Overview
13.17.5 Apotex Latest Developments
13.18 Yung Shin Pharmaceutical
13.18.1 Yung Shin Pharmaceutical Company Information
13.18.2 Yung Shin Pharmaceutical Meloxicam Product Portfolios and Specifications
13.18.3 Yung Shin Pharmaceutical Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Yung Shin Pharmaceutical Main Business Overview
13.18.5 Yung Shin Pharmaceutical Latest Developments
13.19 Breckenridge Pharmaceutical
13.19.1 Breckenridge Pharmaceutical Company Information
13.19.2 Breckenridge Pharmaceutical Meloxicam Product Portfolios and Specifications
13.19.3 Breckenridge Pharmaceutical Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Breckenridge Pharmaceutical Main Business Overview
13.19.5 Breckenridge Pharmaceutical Latest Developments
13.20 Zydus Pharmaceuticals
13.20.1 Zydus Pharmaceuticals Company Information
13.20.2 Zydus Pharmaceuticals Meloxicam Product Portfolios and Specifications
13.20.3 Zydus Pharmaceuticals Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Zydus Pharmaceuticals Main Business Overview
13.20.5 Zydus Pharmaceuticals Latest Developments
13.21 Unichem Pharmaceuticals
13.21.1 Unichem Pharmaceuticals Company Information
13.21.2 Unichem Pharmaceuticals Meloxicam Product Portfolios and Specifications
13.21.3 Unichem Pharmaceuticals Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Unichem Pharmaceuticals Main Business Overview
13.21.5 Unichem Pharmaceuticals Latest Developments
13.22 Strides Pharma
13.22.1 Strides Pharma Company Information
13.22.2 Strides Pharma Meloxicam Product Portfolios and Specifications
13.22.3 Strides Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 Strides Pharma Main Business Overview
13.22.5 Strides Pharma Latest Developments
13.23 Cipla
13.23.1 Cipla Company Information
13.23.2 Cipla Meloxicam Product Portfolios and Specifications
13.23.3 Cipla Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 Cipla Main Business Overview
13.23.5 Cipla Latest Developments
13.24 Dr. Reddy's Laboratories
13.24.1 Dr. Reddy's Laboratories Company Information
13.24.2 Dr. Reddy's Laboratories Meloxicam Product Portfolios and Specifications
13.24.3 Dr. Reddy's Laboratories Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.24.4 Dr. Reddy's Laboratories Main Business Overview
13.24.5 Dr. Reddy's Laboratories Latest Developments
13.25 Glenmark Pharmaceuticals
13.25.1 Glenmark Pharmaceuticals Company Information
13.25.2 Glenmark Pharmaceuticals Meloxicam Product Portfolios and Specifications
13.25.3 Glenmark Pharmaceuticals Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.25.4 Glenmark Pharmaceuticals Main Business Overview
13.25.5 Glenmark Pharmaceuticals Latest Developments
13.26 Teva
13.26.1 Teva Company Information
13.26.2 Teva Meloxicam Product Portfolios and Specifications
13.26.3 Teva Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.26.4 Teva Main Business Overview
13.26.5 Teva Latest Developments
13.27 PuraCap Pharmaceutical
13.27.1 PuraCap Pharmaceutical Company Information
13.27.2 PuraCap Pharmaceutical Meloxicam Product Portfolios and Specifications
13.27.3 PuraCap Pharmaceutical Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.27.4 PuraCap Pharmaceutical Main Business Overview
13.27.5 PuraCap Pharmaceutical Latest Developments
13.28 TARO
13.28.1 TARO Company Information
13.28.2 TARO Meloxicam Product Portfolios and Specifications
13.28.3 TARO Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.28.4 TARO Main Business Overview
13.28.5 TARO Latest Developments
13.29 Lupin Pharmaceuticals
13.29.1 Lupin Pharmaceuticals Company Information
13.29.2 Lupin Pharmaceuticals Meloxicam Product Portfolios and Specifications
13.29.3 Lupin Pharmaceuticals Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.29.4 Lupin Pharmaceuticals Main Business Overview
13.29.5 Lupin Pharmaceuticals Latest Developments
13.30 Aurobindo Pharma
13.30.1 Aurobindo Pharma Company Information
13.30.2 Aurobindo Pharma Meloxicam Product Portfolios and Specifications
13.30.3 Aurobindo Pharma Meloxicam Sales, Revenue, Price and Gross Margin (2018-2023)
13.30.4 Aurobindo Pharma Main Business Overview
13.30.5 Aurobindo Pharma Latest Developments
13.31 Shanghai Bolinger Ingelheim Pharmaceutical
13.32 Shanghai Zhaohui Pharmaceutical
13.33 Sichuan Shenghe Pharmaceutical
13.34 Ningxia Kangya Pharmaceutical
13.35 Yangtze Pharmaceutical Group
13.36 Kunshan Longdeng Ruidi Pharmaceutical
13.37 Jiangsu Yabang Epson Pharmaceutical
13.38 Jiangsu Feima Pharmaceutical Co. , Ltd
13.39 Zhejiang Xianju Pharmaceutical
13.40 Hainan All Star Pharmaceutical
13.41 Hainan Aomeihua Pharmaceutical
13.42 Hunan Mingrui Pharmaceutical
13.43 Suzhou Sinochem Pharmaceutical
13.44 Qilu Pharmaceutical
13.45 Sichuan Luye Pharmaceutical
13.46 Shandong Xinhua Pharmaceutical
13.47 Guangdong Renkang Pharmaceutical
13.48 Hainan Selike Pharmaceutical
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Meloxicam Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Meloxicam Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Combination Drugs
Table 4. Major Players of Prescribed Drugs
Table 5. Global Meloxicam Sales by Type (2018-2023) & (KG)
Table 6. Global Meloxicam Sales Market Share by Type (2018-2023)
Table 7. Global Meloxicam Revenue by Type (2018-2023) & ($ million)
Table 8. Global Meloxicam Revenue Market Share by Type (2018-2023)
Table 9. Global Meloxicam Sale Price by Type (2018-2023) & (US$/G)
Table 10. Global Meloxicam Sales by Application (2018-2023) & (KG)
Table 11. Global Meloxicam Sales Market Share by Application (2018-2023)
Table 12. Global Meloxicam Revenue by Application (2018-2023)
Table 13. Global Meloxicam Revenue Market Share by Application (2018-2023)
Table 14. Global Meloxicam Sale Price by Application (2018-2023) & (US$/G)
Table 15. Global Meloxicam Sales by Company (2018-2023) & (KG)
Table 16. Global Meloxicam Sales Market Share by Company (2018-2023)
Table 17. Global Meloxicam Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Meloxicam Revenue Market Share by Company (2018-2023)
Table 19. Global Meloxicam Sale Price by Company (2018-2023) & (US$/G)
Table 20. Key Manufacturers Meloxicam Producing Area Distribution and Sales Area
Table 21. Players Meloxicam Products Offered
Table 22. Meloxicam Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Meloxicam Sales by Geographic Region (2018-2023) & (KG)
Table 26. Global Meloxicam Sales Market Share Geographic Region (2018-2023)
Table 27. Global Meloxicam Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Meloxicam Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Meloxicam Sales by Country/Region (2018-2023) & (KG)
Table 30. Global Meloxicam Sales Market Share by Country/Region (2018-2023)
Table 31. Global Meloxicam Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Meloxicam Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Meloxicam Sales by Country (2018-2023) & (KG)
Table 34. Americas Meloxicam Sales Market Share by Country (2018-2023)
Table 35. Americas Meloxicam Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Meloxicam Revenue Market Share by Country (2018-2023)
Table 37. Americas Meloxicam Sales by Type (2018-2023) & (KG)
Table 38. Americas Meloxicam Sales by Application (2018-2023) & (KG)
Table 39. APAC Meloxicam Sales by Region (2018-2023) & (KG)
Table 40. APAC Meloxicam Sales Market Share by Region (2018-2023)
Table 41. APAC Meloxicam Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Meloxicam Revenue Market Share by Region (2018-2023)
Table 43. APAC Meloxicam Sales by Type (2018-2023) & (KG)
Table 44. APAC Meloxicam Sales by Application (2018-2023) & (KG)
Table 45. Europe Meloxicam Sales by Country (2018-2023) & (KG)
Table 46. Europe Meloxicam Sales Market Share by Country (2018-2023)
Table 47. Europe Meloxicam Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Meloxicam Revenue Market Share by Country (2018-2023)
Table 49. Europe Meloxicam Sales by Type (2018-2023) & (KG)
Table 50. Europe Meloxicam Sales by Application (2018-2023) & (KG)
Table 51. Middle East & Africa Meloxicam Sales by Country (2018-2023) & (KG)
Table 52. Middle East & Africa Meloxicam Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Meloxicam Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Meloxicam Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Meloxicam Sales by Type (2018-2023) & (KG)
Table 56. Middle East & Africa Meloxicam Sales by Application (2018-2023) & (KG)
Table 57. Key Market Drivers & Growth Opportunities of Meloxicam
Table 58. Key Market Challenges & Risks of Meloxicam
Table 59. Key Industry Trends of Meloxicam
Table 60. Meloxicam Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Meloxicam Distributors List
Table 63. Meloxicam Customer List
Table 64. Global Meloxicam Sales Forecast by Region (2024-2029) & (KG)
Table 65. Global Meloxicam Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Meloxicam Sales Forecast by Country (2024-2029) & (KG)
Table 67. Americas Meloxicam Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Meloxicam Sales Forecast by Region (2024-2029) & (KG)
Table 69. APAC Meloxicam Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Meloxicam Sales Forecast by Country (2024-2029) & (KG)
Table 71. Europe Meloxicam Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Meloxicam Sales Forecast by Country (2024-2029) & (KG)
Table 73. Middle East & Africa Meloxicam Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Meloxicam Sales Forecast by Type (2024-2029) & (KG)
Table 75. Global Meloxicam Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Meloxicam Sales Forecast by Application (2024-2029) & (KG)
Table 77. Global Meloxicam Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Boehringer Ingelheim Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 79. Boehringer Ingelheim Meloxicam Product Portfolios and Specifications
Table 80. Boehringer Ingelheim Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 81. Boehringer Ingelheim Main Business
Table 82. Boehringer Ingelheim Latest Developments
Table 83. Baudax Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 84. Baudax Meloxicam Product Portfolios and Specifications
Table 85. Baudax Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 86. Baudax Main Business
Table 87. Baudax Latest Developments
Table 88. Perrigo Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 89. Perrigo Meloxicam Product Portfolios and Specifications
Table 90. Perrigo Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 91. Perrigo Main Business
Table 92. Perrigo Latest Developments
Table 93. Recro Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 94. Recro Pharma Meloxicam Product Portfolios and Specifications
Table 95. Recro Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 96. Recro Pharma Main Business
Table 97. Recro Pharma Latest Developments
Table 98. Iroko Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 99. Iroko Pharma Meloxicam Product Portfolios and Specifications
Table 100. Iroko Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 101. Iroko Pharma Main Business
Table 102. Iroko Pharma Latest Developments
Table 103. Zyla Life Sciences Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 104. Zyla Life Sciences Meloxicam Product Portfolios and Specifications
Table 105. Zyla Life Sciences Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 106. Zyla Life Sciences Main Business
Table 107. Zyla Life Sciences Latest Developments
Table 108. Axsome Therapeutics Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 109. Axsome Therapeutics Meloxicam Product Portfolios and Specifications
Table 110. Axsome Therapeutics Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 111. Axsome Therapeutics Main Business
Table 112. Axsome Therapeutics Latest Developments
Table 113. Orbis Biosciences Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 114. Orbis Biosciences Meloxicam Product Portfolios and Specifications
Table 115. Orbis Biosciences Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 116. Orbis Biosciences Main Business
Table 117. Orbis Biosciences Latest Developments
Table 118. Cellix Bio Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 119. Cellix Bio Meloxicam Product Portfolios and Specifications
Table 120. Cellix Bio Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 121. Cellix Bio Main Business
Table 122. Cellix Bio Latest Developments
Table 123. Ligand Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 124. Ligand Pharma Meloxicam Product Portfolios and Specifications
Table 125. Ligand Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 126. Ligand Pharma Main Business
Table 127. Ligand Pharma Latest Developments
Table 128. SEDOR Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 129. SEDOR Pharma Meloxicam Product Portfolios and Specifications
Table 130. SEDOR Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 131. SEDOR Pharma Main Business
Table 132. SEDOR Pharma Latest Developments
Table 133. Heron Therapeutics Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 134. Heron Therapeutics Meloxicam Product Portfolios and Specifications
Table 135. Heron Therapeutics Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 136. Heron Therapeutics Main Business
Table 137. Heron Therapeutics Latest Developments
Table 138. Pacira BioSciences Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 139. Pacira BioSciences Meloxicam Product Portfolios and Specifications
Table 140. Pacira BioSciences Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 141. Pacira BioSciences Main Business
Table 142. Pacira BioSciences Latest Developments
Table 143. Sanofi Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 144. Sanofi Meloxicam Product Portfolios and Specifications
Table 145. Sanofi Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 146. Sanofi Main Business
Table 147. Sanofi Latest Developments
Table 148. Eurofarma Laboratorio Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 149. Eurofarma Laboratorio Meloxicam Product Portfolios and Specifications
Table 150. Eurofarma Laboratorio Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 151. Eurofarma Laboratorio Main Business
Table 152. Eurofarma Laboratorio Latest Developments
Table 153. TerSera Therapeutics Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 154. TerSera Therapeutics Meloxicam Product Portfolios and Specifications
Table 155. TerSera Therapeutics Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 156. TerSera Therapeutics Main Business
Table 157. TerSera Therapeutics Latest Developments
Table 158. Apotex Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 159. Apotex Meloxicam Product Portfolios and Specifications
Table 160. Apotex Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 161. Apotex Main Business
Table 162. Apotex Latest Developments
Table 163. Yung Shin Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 164. Yung Shin Pharmaceutical Meloxicam Product Portfolios and Specifications
Table 165. Yung Shin Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 166. Yung Shin Pharmaceutical Main Business
Table 167. Yung Shin Pharmaceutical Latest Developments
Table 168. Breckenridge Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 169. Breckenridge Pharmaceutical Meloxicam Product Portfolios and Specifications
Table 170. Breckenridge Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 171. Breckenridge Pharmaceutical Main Business
Table 172. Breckenridge Pharmaceutical Latest Developments
Table 173. Zydus Pharmaceuticals Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 174. Zydus Pharmaceuticals Meloxicam Product Portfolios and Specifications
Table 175. Zydus Pharmaceuticals Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 176. Zydus Pharmaceuticals Main Business
Table 177. Zydus Pharmaceuticals Latest Developments
Table 178. Unichem Pharmaceuticals Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 179. Unichem Pharmaceuticals Meloxicam Product Portfolios and Specifications
Table 180. Unichem Pharmaceuticals Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 181. Unichem Pharmaceuticals Main Business
Table 182. Unichem Pharmaceuticals Latest Developments
Table 183. Strides Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 184. Strides Pharma Meloxicam Product Portfolios and Specifications
Table 185. Strides Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 186. Strides Pharma Main Business
Table 187. Strides Pharma Latest Developments
Table 188. Cipla Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 189. Cipla Meloxicam Product Portfolios and Specifications
Table 190. Cipla Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 191. Cipla Main Business
Table 192. Cipla Latest Developments
Table 193. Dr. Reddy's Laboratories Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 194. Dr. Reddy's Laboratories Meloxicam Product Portfolios and Specifications
Table 195. Dr. Reddy's Laboratories Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 196. Dr. Reddy's Laboratories Main Business
Table 197. Dr. Reddy's Laboratories Latest Developments
Table 198. Glenmark Pharmaceuticals Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 199. Glenmark Pharmaceuticals Meloxicam Product Portfolios and Specifications
Table 200. Glenmark Pharmaceuticals Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 201. Glenmark Pharmaceuticals Main Business
Table 202. Glenmark Pharmaceuticals Latest Developments
Table 203. Teva Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 204. Teva Meloxicam Product Portfolios and Specifications
Table 205. Teva Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 206. Teva Main Business
Table 207. Teva Latest Developments
Table 208. PuraCap Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 209. PuraCap Pharmaceutical Meloxicam Product Portfolios and Specifications
Table 210. PuraCap Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 211. PuraCap Pharmaceutical Main Business
Table 212. PuraCap Pharmaceutical Latest Developments
Table 213. TARO Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 214. TARO Meloxicam Product Portfolios and Specifications
Table 215. TARO Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 216. TARO Main Business
Table 217. TARO Latest Developments
Table 218. Lupin Pharmaceuticals Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 219. Lupin Pharmaceuticals Meloxicam Product Portfolios and Specifications
Table 220. Lupin Pharmaceuticals Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 221. Lupin Pharmaceuticals Main Business
Table 222. Lupin Pharmaceuticals Latest Developments
Table 223. Aurobindo Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 224. Aurobindo Pharma Meloxicam Product Portfolios and Specifications
Table 225. Aurobindo Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 226. Aurobindo Pharma Main Business
Table 227. Aurobindo Pharma Latest Developments
Table 228. Shanghai Bolinger Ingelheim Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 229. Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Product Portfolios and Specifications
Table 230. Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 231. Shanghai Bolinger Ingelheim Pharmaceutical Main Business
Table 232. Shanghai Bolinger Ingelheim Pharmaceutical Latest Developments
Table 233. Shanghai Zhaohui Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 234. Shanghai Zhaohui Pharmaceutical Meloxicam Product Portfolios and Specifications
Table 235. Shanghai Zhaohui Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 236. Shanghai Zhaohui Pharmaceutical Main Business
Table 237. Shanghai Zhaohui Pharmaceutical Latest Developments
Table 238. Sichuan Shenghe Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 239. Sichuan Shenghe Pharmaceutical Meloxicam Product Portfolios and Specifications
Table 240. Sichuan Shenghe Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 241. Sichuan Shenghe Pharmaceutical Main Business
Table 242. Sichuan Shenghe Pharmaceutical Latest Developments
Table 243. Ningxia Kangya Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 244. Ningxia Kangya Pharmaceutical Meloxicam Product Portfolios and Specifications
Table 245. Ningxia Kangya Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 246. Ningxia Kangya Pharmaceutical Main Business
Table 247. Ningxia Kangya Pharmaceutical Latest Developments
Table 248. Yangtze Pharmaceutical Group Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 249. Yangtze Pharmaceutical Group Meloxicam Product Portfolios and Specifications
Table 250. Yangtze Pharmaceutical Group Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 251. Yangtze Pharmaceutical Group Main Business
Table 252. Yangtze Pharmaceutical Group Latest Developments
Table 253. Kunshan Longdeng Ruidi Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 254. Jiangsu Yabang Epson Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 255. Jiangsu Feima Pharmaceutical Co. , Ltd Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 256. Zhejiang Xianju Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 257. Hainan All Star Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 258. Hainan Aomeihua Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 259. Hunan Mingrui Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 260. Suzhou Sinochem Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 261. Qilu Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 262. Sichuan Luye Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 263. Shandong Xinhua Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 264. Guangdong Renkang Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 265. Hainan Selike Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 1. Meloxicam Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Meloxicam Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Combination Drugs
Table 4. Major Players of Prescribed Drugs
Table 5. Global Meloxicam Sales by Type (2018-2023) & (KG)
Table 6. Global Meloxicam Sales Market Share by Type (2018-2023)
Table 7. Global Meloxicam Revenue by Type (2018-2023) & ($ million)
Table 8. Global Meloxicam Revenue Market Share by Type (2018-2023)
Table 9. Global Meloxicam Sale Price by Type (2018-2023) & (US$/G)
Table 10. Global Meloxicam Sales by Application (2018-2023) & (KG)
Table 11. Global Meloxicam Sales Market Share by Application (2018-2023)
Table 12. Global Meloxicam Revenue by Application (2018-2023)
Table 13. Global Meloxicam Revenue Market Share by Application (2018-2023)
Table 14. Global Meloxicam Sale Price by Application (2018-2023) & (US$/G)
Table 15. Global Meloxicam Sales by Company (2018-2023) & (KG)
Table 16. Global Meloxicam Sales Market Share by Company (2018-2023)
Table 17. Global Meloxicam Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Meloxicam Revenue Market Share by Company (2018-2023)
Table 19. Global Meloxicam Sale Price by Company (2018-2023) & (US$/G)
Table 20. Key Manufacturers Meloxicam Producing Area Distribution and Sales Area
Table 21. Players Meloxicam Products Offered
Table 22. Meloxicam Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Meloxicam Sales by Geographic Region (2018-2023) & (KG)
Table 26. Global Meloxicam Sales Market Share Geographic Region (2018-2023)
Table 27. Global Meloxicam Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Meloxicam Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Meloxicam Sales by Country/Region (2018-2023) & (KG)
Table 30. Global Meloxicam Sales Market Share by Country/Region (2018-2023)
Table 31. Global Meloxicam Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Meloxicam Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Meloxicam Sales by Country (2018-2023) & (KG)
Table 34. Americas Meloxicam Sales Market Share by Country (2018-2023)
Table 35. Americas Meloxicam Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Meloxicam Revenue Market Share by Country (2018-2023)
Table 37. Americas Meloxicam Sales by Type (2018-2023) & (KG)
Table 38. Americas Meloxicam Sales by Application (2018-2023) & (KG)
Table 39. APAC Meloxicam Sales by Region (2018-2023) & (KG)
Table 40. APAC Meloxicam Sales Market Share by Region (2018-2023)
Table 41. APAC Meloxicam Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Meloxicam Revenue Market Share by Region (2018-2023)
Table 43. APAC Meloxicam Sales by Type (2018-2023) & (KG)
Table 44. APAC Meloxicam Sales by Application (2018-2023) & (KG)
Table 45. Europe Meloxicam Sales by Country (2018-2023) & (KG)
Table 46. Europe Meloxicam Sales Market Share by Country (2018-2023)
Table 47. Europe Meloxicam Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Meloxicam Revenue Market Share by Country (2018-2023)
Table 49. Europe Meloxicam Sales by Type (2018-2023) & (KG)
Table 50. Europe Meloxicam Sales by Application (2018-2023) & (KG)
Table 51. Middle East & Africa Meloxicam Sales by Country (2018-2023) & (KG)
Table 52. Middle East & Africa Meloxicam Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Meloxicam Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Meloxicam Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Meloxicam Sales by Type (2018-2023) & (KG)
Table 56. Middle East & Africa Meloxicam Sales by Application (2018-2023) & (KG)
Table 57. Key Market Drivers & Growth Opportunities of Meloxicam
Table 58. Key Market Challenges & Risks of Meloxicam
Table 59. Key Industry Trends of Meloxicam
Table 60. Meloxicam Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Meloxicam Distributors List
Table 63. Meloxicam Customer List
Table 64. Global Meloxicam Sales Forecast by Region (2024-2029) & (KG)
Table 65. Global Meloxicam Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Meloxicam Sales Forecast by Country (2024-2029) & (KG)
Table 67. Americas Meloxicam Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Meloxicam Sales Forecast by Region (2024-2029) & (KG)
Table 69. APAC Meloxicam Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Meloxicam Sales Forecast by Country (2024-2029) & (KG)
Table 71. Europe Meloxicam Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Meloxicam Sales Forecast by Country (2024-2029) & (KG)
Table 73. Middle East & Africa Meloxicam Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Meloxicam Sales Forecast by Type (2024-2029) & (KG)
Table 75. Global Meloxicam Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Meloxicam Sales Forecast by Application (2024-2029) & (KG)
Table 77. Global Meloxicam Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Boehringer Ingelheim Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 79. Boehringer Ingelheim Meloxicam Product Portfolios and Specifications
Table 80. Boehringer Ingelheim Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 81. Boehringer Ingelheim Main Business
Table 82. Boehringer Ingelheim Latest Developments
Table 83. Baudax Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 84. Baudax Meloxicam Product Portfolios and Specifications
Table 85. Baudax Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 86. Baudax Main Business
Table 87. Baudax Latest Developments
Table 88. Perrigo Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 89. Perrigo Meloxicam Product Portfolios and Specifications
Table 90. Perrigo Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 91. Perrigo Main Business
Table 92. Perrigo Latest Developments
Table 93. Recro Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 94. Recro Pharma Meloxicam Product Portfolios and Specifications
Table 95. Recro Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 96. Recro Pharma Main Business
Table 97. Recro Pharma Latest Developments
Table 98. Iroko Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 99. Iroko Pharma Meloxicam Product Portfolios and Specifications
Table 100. Iroko Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 101. Iroko Pharma Main Business
Table 102. Iroko Pharma Latest Developments
Table 103. Zyla Life Sciences Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 104. Zyla Life Sciences Meloxicam Product Portfolios and Specifications
Table 105. Zyla Life Sciences Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 106. Zyla Life Sciences Main Business
Table 107. Zyla Life Sciences Latest Developments
Table 108. Axsome Therapeutics Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 109. Axsome Therapeutics Meloxicam Product Portfolios and Specifications
Table 110. Axsome Therapeutics Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 111. Axsome Therapeutics Main Business
Table 112. Axsome Therapeutics Latest Developments
Table 113. Orbis Biosciences Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 114. Orbis Biosciences Meloxicam Product Portfolios and Specifications
Table 115. Orbis Biosciences Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 116. Orbis Biosciences Main Business
Table 117. Orbis Biosciences Latest Developments
Table 118. Cellix Bio Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 119. Cellix Bio Meloxicam Product Portfolios and Specifications
Table 120. Cellix Bio Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 121. Cellix Bio Main Business
Table 122. Cellix Bio Latest Developments
Table 123. Ligand Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 124. Ligand Pharma Meloxicam Product Portfolios and Specifications
Table 125. Ligand Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 126. Ligand Pharma Main Business
Table 127. Ligand Pharma Latest Developments
Table 128. SEDOR Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 129. SEDOR Pharma Meloxicam Product Portfolios and Specifications
Table 130. SEDOR Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 131. SEDOR Pharma Main Business
Table 132. SEDOR Pharma Latest Developments
Table 133. Heron Therapeutics Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 134. Heron Therapeutics Meloxicam Product Portfolios and Specifications
Table 135. Heron Therapeutics Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 136. Heron Therapeutics Main Business
Table 137. Heron Therapeutics Latest Developments
Table 138. Pacira BioSciences Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 139. Pacira BioSciences Meloxicam Product Portfolios and Specifications
Table 140. Pacira BioSciences Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 141. Pacira BioSciences Main Business
Table 142. Pacira BioSciences Latest Developments
Table 143. Sanofi Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 144. Sanofi Meloxicam Product Portfolios and Specifications
Table 145. Sanofi Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 146. Sanofi Main Business
Table 147. Sanofi Latest Developments
Table 148. Eurofarma Laboratorio Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 149. Eurofarma Laboratorio Meloxicam Product Portfolios and Specifications
Table 150. Eurofarma Laboratorio Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 151. Eurofarma Laboratorio Main Business
Table 152. Eurofarma Laboratorio Latest Developments
Table 153. TerSera Therapeutics Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 154. TerSera Therapeutics Meloxicam Product Portfolios and Specifications
Table 155. TerSera Therapeutics Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 156. TerSera Therapeutics Main Business
Table 157. TerSera Therapeutics Latest Developments
Table 158. Apotex Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 159. Apotex Meloxicam Product Portfolios and Specifications
Table 160. Apotex Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 161. Apotex Main Business
Table 162. Apotex Latest Developments
Table 163. Yung Shin Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 164. Yung Shin Pharmaceutical Meloxicam Product Portfolios and Specifications
Table 165. Yung Shin Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 166. Yung Shin Pharmaceutical Main Business
Table 167. Yung Shin Pharmaceutical Latest Developments
Table 168. Breckenridge Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 169. Breckenridge Pharmaceutical Meloxicam Product Portfolios and Specifications
Table 170. Breckenridge Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 171. Breckenridge Pharmaceutical Main Business
Table 172. Breckenridge Pharmaceutical Latest Developments
Table 173. Zydus Pharmaceuticals Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 174. Zydus Pharmaceuticals Meloxicam Product Portfolios and Specifications
Table 175. Zydus Pharmaceuticals Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 176. Zydus Pharmaceuticals Main Business
Table 177. Zydus Pharmaceuticals Latest Developments
Table 178. Unichem Pharmaceuticals Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 179. Unichem Pharmaceuticals Meloxicam Product Portfolios and Specifications
Table 180. Unichem Pharmaceuticals Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 181. Unichem Pharmaceuticals Main Business
Table 182. Unichem Pharmaceuticals Latest Developments
Table 183. Strides Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 184. Strides Pharma Meloxicam Product Portfolios and Specifications
Table 185. Strides Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 186. Strides Pharma Main Business
Table 187. Strides Pharma Latest Developments
Table 188. Cipla Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 189. Cipla Meloxicam Product Portfolios and Specifications
Table 190. Cipla Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 191. Cipla Main Business
Table 192. Cipla Latest Developments
Table 193. Dr. Reddy's Laboratories Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 194. Dr. Reddy's Laboratories Meloxicam Product Portfolios and Specifications
Table 195. Dr. Reddy's Laboratories Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 196. Dr. Reddy's Laboratories Main Business
Table 197. Dr. Reddy's Laboratories Latest Developments
Table 198. Glenmark Pharmaceuticals Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 199. Glenmark Pharmaceuticals Meloxicam Product Portfolios and Specifications
Table 200. Glenmark Pharmaceuticals Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 201. Glenmark Pharmaceuticals Main Business
Table 202. Glenmark Pharmaceuticals Latest Developments
Table 203. Teva Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 204. Teva Meloxicam Product Portfolios and Specifications
Table 205. Teva Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 206. Teva Main Business
Table 207. Teva Latest Developments
Table 208. PuraCap Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 209. PuraCap Pharmaceutical Meloxicam Product Portfolios and Specifications
Table 210. PuraCap Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 211. PuraCap Pharmaceutical Main Business
Table 212. PuraCap Pharmaceutical Latest Developments
Table 213. TARO Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 214. TARO Meloxicam Product Portfolios and Specifications
Table 215. TARO Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 216. TARO Main Business
Table 217. TARO Latest Developments
Table 218. Lupin Pharmaceuticals Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 219. Lupin Pharmaceuticals Meloxicam Product Portfolios and Specifications
Table 220. Lupin Pharmaceuticals Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 221. Lupin Pharmaceuticals Main Business
Table 222. Lupin Pharmaceuticals Latest Developments
Table 223. Aurobindo Pharma Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 224. Aurobindo Pharma Meloxicam Product Portfolios and Specifications
Table 225. Aurobindo Pharma Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 226. Aurobindo Pharma Main Business
Table 227. Aurobindo Pharma Latest Developments
Table 228. Shanghai Bolinger Ingelheim Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 229. Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Product Portfolios and Specifications
Table 230. Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 231. Shanghai Bolinger Ingelheim Pharmaceutical Main Business
Table 232. Shanghai Bolinger Ingelheim Pharmaceutical Latest Developments
Table 233. Shanghai Zhaohui Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 234. Shanghai Zhaohui Pharmaceutical Meloxicam Product Portfolios and Specifications
Table 235. Shanghai Zhaohui Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 236. Shanghai Zhaohui Pharmaceutical Main Business
Table 237. Shanghai Zhaohui Pharmaceutical Latest Developments
Table 238. Sichuan Shenghe Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 239. Sichuan Shenghe Pharmaceutical Meloxicam Product Portfolios and Specifications
Table 240. Sichuan Shenghe Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 241. Sichuan Shenghe Pharmaceutical Main Business
Table 242. Sichuan Shenghe Pharmaceutical Latest Developments
Table 243. Ningxia Kangya Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 244. Ningxia Kangya Pharmaceutical Meloxicam Product Portfolios and Specifications
Table 245. Ningxia Kangya Pharmaceutical Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 246. Ningxia Kangya Pharmaceutical Main Business
Table 247. Ningxia Kangya Pharmaceutical Latest Developments
Table 248. Yangtze Pharmaceutical Group Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 249. Yangtze Pharmaceutical Group Meloxicam Product Portfolios and Specifications
Table 250. Yangtze Pharmaceutical Group Meloxicam Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 251. Yangtze Pharmaceutical Group Main Business
Table 252. Yangtze Pharmaceutical Group Latest Developments
Table 253. Kunshan Longdeng Ruidi Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 254. Jiangsu Yabang Epson Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 255. Jiangsu Feima Pharmaceutical Co. , Ltd Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 256. Zhejiang Xianju Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 257. Hainan All Star Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 258. Hainan Aomeihua Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 259. Hunan Mingrui Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 260. Suzhou Sinochem Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 261. Qilu Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 262. Sichuan Luye Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 263. Shandong Xinhua Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 264. Guangdong Renkang Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
Table 265. Hainan Selike Pharmaceutical Basic Information, Meloxicam Manufacturing Base, Sales Area and Its Competitors
LIST OF FIGURES
Figure 1. Picture of Meloxicam
Figure 2. Meloxicam Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Meloxicam Sales Growth Rate 2018-2029 (KG)
Figure 7. Global Meloxicam Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Meloxicam Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Combination Drugs
Figure 10. Product Picture of Prescribed Drugs
Figure 11. Global Meloxicam Sales Market Share by Type in 2022
Figure 12. Global Meloxicam Revenue Market Share by Type (2018-2023)
Figure 13. Meloxicam Consumed in Rheumatoid Arthritis
Figure 14. Global Meloxicam Market: Rheumatoid Arthritis (2018-2023) & (KG)
Figure 15. Meloxicam Consumed in Osteoarthritis
Figure 16. Global Meloxicam Market: Osteoarthritis (2018-2023) & (KG)
Figure 17. Meloxicam Consumed in Soft Tissue Inflammation
Figure 18. Global Meloxicam Market: Soft Tissue Inflammation (2018-2023) & (KG)
Figure 19. Meloxicam Consumed in Traumatic Pain
Figure 20. Global Meloxicam Market: Traumatic Pain (2018-2023) & (KG)
Figure 21. Meloxicam Consumed in Post-Operative Pain
Figure 22. Global Meloxicam Market: Post-Operative Pain (2018-2023) & (KG)
Figure 23. Meloxicam Consumed in Other
Figure 24. Global Meloxicam Market: Other (2018-2023) & (KG)
Figure 25. Global Meloxicam Sales Market Share by Application (2022)
Figure 26. Global Meloxicam Revenue Market Share by Application in 2022
Figure 27. Meloxicam Sales Market by Company in 2022 (KG)
Figure 28. Global Meloxicam Sales Market Share by Company in 2022
Figure 29. Meloxicam Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Meloxicam Revenue Market Share by Company in 2022
Figure 31. Global Meloxicam Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Meloxicam Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Meloxicam Sales 2018-2023 (KG)
Figure 34. Americas Meloxicam Revenue 2018-2023 ($ Millions)
Figure 35. APAC Meloxicam Sales 2018-2023 (KG)
Figure 36. APAC Meloxicam Revenue 2018-2023 ($ Millions)
Figure 37. Europe Meloxicam Sales 2018-2023 (KG)
Figure 38. Europe Meloxicam Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Meloxicam Sales 2018-2023 (KG)
Figure 40. Middle East & Africa Meloxicam Revenue 2018-2023 ($ Millions)
Figure 41. Americas Meloxicam Sales Market Share by Country in 2022
Figure 42. Americas Meloxicam Revenue Market Share by Country in 2022
Figure 43. Americas Meloxicam Sales Market Share by Type (2018-2023)
Figure 44. Americas Meloxicam Sales Market Share by Application (2018-2023)
Figure 45. United States Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Meloxicam Sales Market Share by Region in 2022
Figure 50. APAC Meloxicam Revenue Market Share by Regions in 2022
Figure 51. APAC Meloxicam Sales Market Share by Type (2018-2023)
Figure 52. APAC Meloxicam Sales Market Share by Application (2018-2023)
Figure 53. China Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Meloxicam Sales Market Share by Country in 2022
Figure 61. Europe Meloxicam Revenue Market Share by Country in 2022
Figure 62. Europe Meloxicam Sales Market Share by Type (2018-2023)
Figure 63. Europe Meloxicam Sales Market Share by Application (2018-2023)
Figure 64. Germany Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Meloxicam Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Meloxicam Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Meloxicam Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Meloxicam Sales Market Share by Application (2018-2023)
Figure 73. Egypt Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Meloxicam in 2022
Figure 79. Manufacturing Process Analysis of Meloxicam
Figure 80. Industry Chain Structure of Meloxicam
Figure 81. Channels of Distribution
Figure 82. Global Meloxicam Sales Market Forecast by Region (2024-2029)
Figure 83. Global Meloxicam Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Meloxicam Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Meloxicam Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Meloxicam Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Meloxicam Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Meloxicam
Figure 2. Meloxicam Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Meloxicam Sales Growth Rate 2018-2029 (KG)
Figure 7. Global Meloxicam Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Meloxicam Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Combination Drugs
Figure 10. Product Picture of Prescribed Drugs
Figure 11. Global Meloxicam Sales Market Share by Type in 2022
Figure 12. Global Meloxicam Revenue Market Share by Type (2018-2023)
Figure 13. Meloxicam Consumed in Rheumatoid Arthritis
Figure 14. Global Meloxicam Market: Rheumatoid Arthritis (2018-2023) & (KG)
Figure 15. Meloxicam Consumed in Osteoarthritis
Figure 16. Global Meloxicam Market: Osteoarthritis (2018-2023) & (KG)
Figure 17. Meloxicam Consumed in Soft Tissue Inflammation
Figure 18. Global Meloxicam Market: Soft Tissue Inflammation (2018-2023) & (KG)
Figure 19. Meloxicam Consumed in Traumatic Pain
Figure 20. Global Meloxicam Market: Traumatic Pain (2018-2023) & (KG)
Figure 21. Meloxicam Consumed in Post-Operative Pain
Figure 22. Global Meloxicam Market: Post-Operative Pain (2018-2023) & (KG)
Figure 23. Meloxicam Consumed in Other
Figure 24. Global Meloxicam Market: Other (2018-2023) & (KG)
Figure 25. Global Meloxicam Sales Market Share by Application (2022)
Figure 26. Global Meloxicam Revenue Market Share by Application in 2022
Figure 27. Meloxicam Sales Market by Company in 2022 (KG)
Figure 28. Global Meloxicam Sales Market Share by Company in 2022
Figure 29. Meloxicam Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Meloxicam Revenue Market Share by Company in 2022
Figure 31. Global Meloxicam Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Meloxicam Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Meloxicam Sales 2018-2023 (KG)
Figure 34. Americas Meloxicam Revenue 2018-2023 ($ Millions)
Figure 35. APAC Meloxicam Sales 2018-2023 (KG)
Figure 36. APAC Meloxicam Revenue 2018-2023 ($ Millions)
Figure 37. Europe Meloxicam Sales 2018-2023 (KG)
Figure 38. Europe Meloxicam Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Meloxicam Sales 2018-2023 (KG)
Figure 40. Middle East & Africa Meloxicam Revenue 2018-2023 ($ Millions)
Figure 41. Americas Meloxicam Sales Market Share by Country in 2022
Figure 42. Americas Meloxicam Revenue Market Share by Country in 2022
Figure 43. Americas Meloxicam Sales Market Share by Type (2018-2023)
Figure 44. Americas Meloxicam Sales Market Share by Application (2018-2023)
Figure 45. United States Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Meloxicam Sales Market Share by Region in 2022
Figure 50. APAC Meloxicam Revenue Market Share by Regions in 2022
Figure 51. APAC Meloxicam Sales Market Share by Type (2018-2023)
Figure 52. APAC Meloxicam Sales Market Share by Application (2018-2023)
Figure 53. China Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Meloxicam Sales Market Share by Country in 2022
Figure 61. Europe Meloxicam Revenue Market Share by Country in 2022
Figure 62. Europe Meloxicam Sales Market Share by Type (2018-2023)
Figure 63. Europe Meloxicam Sales Market Share by Application (2018-2023)
Figure 64. Germany Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Meloxicam Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Meloxicam Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Meloxicam Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Meloxicam Sales Market Share by Application (2018-2023)
Figure 73. Egypt Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Meloxicam Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Meloxicam in 2022
Figure 79. Manufacturing Process Analysis of Meloxicam
Figure 80. Industry Chain Structure of Meloxicam
Figure 81. Channels of Distribution
Figure 82. Global Meloxicam Sales Market Forecast by Region (2024-2029)
Figure 83. Global Meloxicam Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Meloxicam Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Meloxicam Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Meloxicam Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Meloxicam Revenue Market Share Forecast by Application (2024-2029)
